GlassScriptPhysician profile
Mario C Cucchiarella
NPI 1790756765
$1,332.08
in general payments reported to CMS, 2019-2025
10 companies · $80.38 in 2025
The $80.38 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $594 · 2020: $227 · 2021: $78.48 · 2022: $198 · 2023: $114 · 2024: $39.20 · 2025: $80.38.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $233.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $322.48 | 2019-2023 | |
| Amgen INC. | $244.82 | 2019 | |
| Janssen Pharmaceuticals, INC | $231.09 | 2019 | |
| Glaxosmithkline, LLC. | $155.43 | 2019-2025 | Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $119.72 | 2022 | |
| Exact Sciences Corporation | $98.72 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $83.34 | 2019-2023 | Pneumovax 23, Vaxneuvance, Gardasil 9 |
| Novartis Pharmaceuticals Corporation | $35.85 | 2019 | |
| Penumbra, INC. | $25.32 | 2025 | Indigo System |
| Lilly USA, LLC | $15.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Cucchiarella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.